- Home
- QTRX vs ELDN Comparison
QTRX vs ELDN Comparison
Compare QTRX & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QTRX
- ELDN
- Stock Information
- Founded
- QTRX 2007
- ELDN 2004
- Country
- QTRX United States
- ELDN United States
- Employees
- QTRX N/A
- ELDN N/A
- Industry
- QTRX Biotechnology: Laboratory Analytical Instruments
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- QTRX Industrials
- ELDN Health Care
- Exchange
- QTRX Nasdaq
- ELDN Nasdaq
- Market Cap
- QTRX 223.6M
- ELDN 178.4M
- IPO Year
- QTRX 2017
- ELDN N/A
- Fundamental
- Price
- QTRX $5.41
- ELDN $3.10
- Analyst Decision
- QTRX Buy
- ELDN Strong Buy
- Analyst Count
- QTRX 5
- ELDN 1
- Target Price
- QTRX $16.20
- ELDN $16.00
- AVG Volume (30 Days)
- QTRX 640.4K
- ELDN 150.4K
- Earning Date
- QTRX 05-12-2025
- ELDN 05-20-2025
- Dividend Yield
- QTRX N/A
- ELDN N/A
- EPS Growth
- QTRX N/A
- ELDN N/A
- EPS
- QTRX N/A
- ELDN N/A
- Revenue
- QTRX $137,421,000.00
- ELDN N/A
- Revenue This Year
- QTRX $5.22
- ELDN N/A
- Revenue Next Year
- QTRX $15.31
- ELDN N/A
- P/E Ratio
- QTRX N/A
- ELDN N/A
- Revenue Growth
- QTRX 12.30
- ELDN N/A
- 52 Week Low
- QTRX $4.67
- ELDN $2.00
- 52 Week High
- QTRX $19.18
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- QTRX 44.83
- ELDN 55.29
- Support Level
- QTRX $5.21
- ELDN $2.85
- Resistance Level
- QTRX $5.75
- ELDN $3.51
- Average True Range (ATR)
- QTRX 0.39
- ELDN 0.23
- MACD
- QTRX 0.05
- ELDN 0.03
- Stochastic Oscillator
- QTRX 35.71
- ELDN 74.65
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.